Signing Day Sports, Inc. has filed Prospectus Supplement No. 8 with the SEC, which includes information from their Current Report on Form 8-K filed on February 28, 2024. This supplement is an addition to the original Prospectus dated November 13, 2023, and subsequent supplements detailing the offering of Representative’s Warrants to purchase up to 96,600 shares of common stock. The company's shares are traded under the symbol 'SGN' on the NYSE American, with the last reported sale price on February 28, 2024, being $0.6999. As an emerging growth company, Signing Day Sports has elected to comply with reduced public company reporting requirements. The Prospectus Supplement also covers the approval by stockholders of amendments to the Certificate of Incorporation to authorize 15,000,000 shares of 'blank-check preferred stock' and the resignation of Richard Symington as President, Chief Technology Officer, and a member of the Board. Additionally, stockholders approved amendments to the 2022 Equity Incentive Plan and the issuance of up to $25,000,000 in common stock under an equity line financing arrangement.

Signing Day Sports, Inc. has filed Prospectus Supplement No. 8 with the SEC, which includes information from their Current Report on Form 8-K filed on February 28, 2024. This supplement is an addition to the original Prospectus dated November 13, 2023, and subsequent supplements detailing the offering of Representative’s Warrants to purchase up to 96,600 shares of common stock. The company's shares are traded under the symbol 'SGN' on the NYSE American, with the last reported sale price on February 28, 2024, being $0.6999. As an emerging growth company, Signing Day Sports has elected to comply with reduced public company reporting requirements. The Prospectus Supplement also covers the approval by stockholders of amendments to the Certificate of Incorporation to authorize 15,000,000 shares of 'blank-check preferred stock' and the resignation of Richard Symington as President, Chief Technology Officer, and a member of the Board. Additionally, stockholders approved amendments to the 2022 Equity Incentive Plan and the issuance of up to $25,000,000 in common stock under an equity line financing arrangement.